AstraZeneca PLC Company Top Insiders
| AZNCF Stock | USD 154.64 0.44 0.29% |
AstraZeneca PLC employs about 42 people. The company is managed by 10 executives with a total tenure of roughly 64 years, averaging almost 6.0 years of service per executive, having 4.2 employees per reported executive. Examination of AstraZeneca PLC's management performance can provide insight into the company performance.
| Pam Cheng President Executive Vice-President of Operations and Information Technology |
| Menelas Pangalos President Executive Vice President - Innovative Medicines |
AstraZeneca |
AstraZeneca PLC Management Team Effectiveness
The company has return on total asset (ROA) of 0.0531 % which means that it generated a profit of $0.0531 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0863 %, meaning that it generated $0.0863 on every $100 dollars invested by stockholders. AstraZeneca PLC's management efficiency ratios could be used to measure how well AstraZeneca PLC manages its routine affairs as well as how well it operates its assets and liabilities.AstraZeneca PLC Workforce Comparison
AstraZeneca PLC is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—General industry is presently estimated at about 793,386. AstraZeneca PLC adds roughly 42.0 in number of employees claiming only tiny portion of equities under Drug Manufacturers—General industry.
The company has Profit Margin (PM) of 0.07 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.19 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.19. AstraZeneca PLC Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. AstraZeneca PLC Price Series Summation is a cross summation of AstraZeneca PLC price series and its benchmark/peer.
AstraZeneca PLC Notable Stakeholders
An AstraZeneca PLC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AstraZeneca PLC often face trade-offs trying to please all of them. AstraZeneca PLC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AstraZeneca PLC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Pam Cheng | Executive Vice-President of Operations and Information Technology | Profile | |
| Menelas Pangalos | Executive Vice President - Innovative Medicines | Profile | |
| Ruud Dobber | Executive Vice President Europe | Profile | |
| Marc Dunoyer | CFO and Executive Director | Profile | |
| Chris Sheldon | Head Relations | Profile | |
| MBA DVM | CEO Director | Profile | |
| Gonzalo Vina | Head Relations | Profile | |
| Aradhana MD | CFO Director | Profile | |
| Katarina Ageborg | Chief Compliance Officer | Profile | |
| Jeffrey Pott | General Counsel | Profile |
About AstraZeneca PLC Management Performance
The success or failure of an entity such as AstraZeneca PLC often depends on how effective the management is. AstraZeneca PLC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AstraZeneca management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AstraZeneca management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 83100 people.
AstraZeneca PLC Workforce Analysis
Traditionally, organizations such as AstraZeneca PLC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AstraZeneca PLC within its industry.AstraZeneca PLC Manpower Efficiency
Return on AstraZeneca PLC Manpower
| Revenue Per Employee | 1.1B | |
| Revenue Per Executive | 4.4B | |
| Net Income Per Employee | 78.3M | |
| Net Income Per Executive | 328.8M |
Complementary Tools for AstraZeneca Pink Sheet analysis
When running AstraZeneca PLC's price analysis, check to measure AstraZeneca PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AstraZeneca PLC is operating at the current time. Most of AstraZeneca PLC's value examination focuses on studying past and present price action to predict the probability of AstraZeneca PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AstraZeneca PLC's price. Additionally, you may evaluate how the addition of AstraZeneca PLC to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |